19.2K(top 2%)
articles
843.2K(top 2%)
citations
4,606(top 2%)
★★ articles
524(top 1%)
★★★ articles
2.2(top 27%)
Avg IF
313(top 1%)
H-Index
484(top 2%)
G-Index
2,666
journals

Most Cited Articles of UCL Medical School in 2021

TitleJournalYearCitations
P065 The road to recovery: developing a new service for urgent face-to-face rheumatology outpatient appointments during the COVID-19 pandemic: a single centre experienceRheumatology202178
Rise in the incidence of abusive head trauma during the COVID-19 pandemicArchives of Disease in Childhood202174
The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosisJournal of Hepatology202150
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5DNephrology Dialysis Transplantation202144
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJournal of Hepatology202141
An update on developments in medical education in response to the COVID-19 pandemic: A BEME scoping review: BEME Guide No. 64Medical Teacher202138
Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort studyLancet Regional Health - Europe, The202137
Twelve tips for conducting a virtual OSCEMedical Teacher202127
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trialEuropean Heart Journal202125
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)Journal of Hepatology202125
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)Clinical Nutrition202123
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practiceKidney International202123
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trialEuropean Heart Journal202122
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular riskMetabolism: Clinical and Experimental202120
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialCirculation202119
Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleedingJournal of Hepatology202119
Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysisClinical Oncology202119
Design, Analysis, and Pitfalls of Clinical Trials Using Ex Situ Liver Machine Perfusion: The International Liver Transplantation Society Consensus GuidelinesTransplantation202117
Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising MortalityHepatology202114
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosisMolecular Metabolism202112
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary AnalysisClinical Journal of the American Society of Nephrology: CJASN202112
Management of bacterial and fungal infections in cirrhosis: The MDRO challengeJournal of Hepatology202111
Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysisRheumatology202111
Understanding angiogenesis and the role of angiogenic growth factors in the vascularisation of engineered tissuesMolecular Biology Reports202111
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trialAmerican Heart Journal202110